Can patent duration hinder medical innovation
Patrick Leoni () and
Alvaro Sandroni ()
Additional contact information
Patrick Leoni: Kedge Business School
Alvaro Sandroni: Northwestern University
International Journal of Health Economics and Management, 2016, vol. 16, issue 4, No 6, 397-406
Abstract:
Abstract We argue that, in the pharmaceutical industry, excessive patent duration can deter investments in innovative treatments in favor of me-too drugs. The point is that too-long durations foster incentives to collude to delay investments in R&D for innovative treatments. We give a set of sufficient conditions for which collusion is a subgame-perfect equilibrium; that is, the threat of punishing any deviator is credible. We then show that reducing current duration always breaks down market discipline, and so does an increase in duration for innovative treatments. Optimal patent duration must then be a trade-off between breaking down market discipline and rewarding innovation.
Keywords: Me-too drugs; Medical innovation; Patent duration; Collusion (search for similar items in EconPapers)
JEL-codes: I1 L1 (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
http://link.springer.com/10.1007/s10754-016-9198-0 Abstract (text/html)
Access to full text is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:kap:ijhcfe:v:16:y:2016:i:4:d:10.1007_s10754-016-9198-0
Ordering information: This journal article can be ordered from
http://www.springer. ... th/journal/10754/PS2
DOI: 10.1007/s10754-016-9198-0
Access Statistics for this article
International Journal of Health Economics and Management is currently edited by Leemore Dafny, Robert Town, Mark Pauly, David Dranove and Pedro Pita Barros
More articles in International Journal of Health Economics and Management from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().